These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8313596)

  • 41. Studies of zidovudine in combination with didanosine and zalcitabine.
    Jablonowski H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S52-6. PubMed ID: 8595509
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group.
    Collier AC; Coombs RW; Schoenfeld DA; Bassett RL; Timpone J; Baruch A; Jones M; Facey K; Whitacre C; McAuliffe VJ; Friedman HM; Merigan TC; Reichman RC; Hooper C; Corey L
    N Engl J Med; 1996 Apr; 334(16):1011-7. PubMed ID: 8598838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytomegalovirus retinitis under combination therapy with zidovudine and dideoxycytidine in advanced human immunodeficiency virus infection.
    Kaulen P; Pham DT; Baranowski E; Wollensak J
    Ger J Ophthalmol; 1993 Nov; 2(6):412-5. PubMed ID: 8312826
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiviral effects of 3'-azido-3'-deoxythymidine, 2',3'-dideoxycytidine, and 2',3'-dideoxyadenosine against simian acquired immunodeficiency syndrome-associated type D retrovirus in vitro.
    Tsai CC; Follis KE; Benveniste RE
    AIDS Res Hum Retroviruses; 1988 Oct; 4(5):359-68. PubMed ID: 2461724
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
    Kelley JA; Litterst CL; Roth JS; Vistica DT; Poplack DG; Cooney DA; Nadkarni M; Balis FM; Broder S; Johns DG
    Drug Metab Dispos; 1987; 15(5):595-601. PubMed ID: 2891473
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dideoxycytidine: current clinical experience and future prospects. A summary.
    Broder S; Yarchoan R
    Am J Med; 1990 May; 88(5B):31S-33S. PubMed ID: 2159708
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of 2-fluorodideoxycytidine (2FddC) in patients infected with human immunodeficiency virus.
    Williams PE; Muirhead GJ; Sereni D; Rousseau FS; Edelman K; Hooker M
    Br J Clin Pharmacol; 1993 Mar; 35(3):255-60. PubMed ID: 8385974
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validated RP-hPLC method for the assay of zalcitabine in drug substance, formulated products and human serum.
    Uslu B; Savaşer A; Ozkan SA; Ozkan Y
    Pharmazie; 2004 Aug; 59(8):604-7. PubMed ID: 15378847
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intracellular and serum stability of liposomal 2',3'-dideoxycytidine. Effect of lipid composition.
    Makabi-Panzu B; Gourde P; Désormeaux A; Bergeron MG
    Cell Mol Biol (Noisy-le-grand); 1998 Mar; 44(2):277-84. PubMed ID: 9593578
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dideoxycytidine (ddC): a potent antiretroviral agent for human immunodeficiency virus infection. An introduction.
    Broder S
    Am J Med; 1990 May; 88(5B):1S. PubMed ID: 2159701
    [No Abstract]   [Full Text] [Related]  

  • 51. Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex.
    Skowron G; Bozzette SA; Lim L; Pettinelli CB; Schaumburg HH; Arezzo J; Fischl MA; Powderly WG; Gocke DJ; Richman DD; Pottage JC; Antoniskis D; McKinley GF; Hyslop NE; Ray G; Simon G; Reed N; LoFaro ML; Uttamchandani RB; Gelb LD; Sperber SJ; Murphy RL; Leedom JM; Grieco MH; Zachary J; Hirsch MS; Spector SA; Bigley J; Soo W; Merigan TC
    Ann Intern Med; 1993 Mar; 118(5):321-30. PubMed ID: 8094279
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Calmodulin inhibitors and calcium channel blockers influence dideoxycytidine renal excretion.
    Enigbokan MA; West D; Preston J; Thompson JO
    Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S15-8. PubMed ID: 8574143
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Zidovudine and other reverse transcriptase inhibitors in the management of human immunodeficiency virus-related disease.
    Matthews SJ; Cersosimo RJ; Spivack ML
    Pharmacotherapy; 1991; 11(6):419-48; discussion 448-9. PubMed ID: 1722897
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunological and virological activity of zalcitabine and zidovudine in combination in HIV-positive people with CD4 cell counts of between 200-500 cells/mm3.
    Ibáñez A; Peraire J; Arnó A; Gutiérrez C; Cervantes M; Colomer J; Villalonga C; Camafort M; Ruiz L; Balaguer M; Vidal F; Richart C; Clotet B
    Antivir Ther; 1997 Apr; 2(2):105-11. PubMed ID: 11322274
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 2',3'-dideoxycytidine permeation of the human erythrocyte membrane.
    Magnani M; Bianchi M; Rossi L; Stocchi V
    Biochem Int; 1989 Aug; 19(2):227-34. PubMed ID: 2554906
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-performance liquid chromatographic determination of 2',3'-dideoxycytidine and 3'-azido-3'-deoxythymidine in plasma using a column-switching technique.
    Mathes LE; Muschik G; Demby L; Polas P; Mellini DW; Issaq HJ; Sams R
    J Chromatogr; 1988 Nov; 432():346-51. PubMed ID: 2851596
    [No Abstract]   [Full Text] [Related]  

  • 57. Synthesis and biological evaluation of 2',3'-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV).
    Lin TS; Luo MZ; Liu MC; Pai SB; Dutschman GE; Cheng YC
    J Med Chem; 1994 Mar; 37(6):798-803. PubMed ID: 8145230
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of pharmacokinetics, safety, tolerance, and activity of combination of zalcitabine and zidovudine in stable, zidovudine-treated pediatric patients with human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 190 Team.
    Bakshi SS; Britto P; Capparelli E; Mofenson L; Fowler MG; Rasheed S; Schoenfeld D; Zimmer B; Frank Y; Yogev R; Jimenez E; Salgo M; Boone G; Pahwa SG
    J Infect Dis; 1997 May; 175(5):1039-50. PubMed ID: 9129064
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Determination of 2',3'-dideoxyadenosine, 2',3'-dideoxyinosine and 2',3'-dideoxycytidine in biological samples.
    Kalin JR; Hill DL
    J Chromatogr; 1988 Sep; 431(1):184-91. PubMed ID: 2853167
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity.
    Chen CH; Vazquez-Padua M; Cheng YC
    Mol Pharmacol; 1991 May; 39(5):625-8. PubMed ID: 1851960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.